B- and T-cell V(D)J-recombination excision circles as indicators of immunological reconstitution in children with acute lymphoblastic leukemia

Cover Page

Cite item

Full Text

Abstract

Acute lymphoblastic leukemia (ALL) is the most common malignant haematological disease of childhood. ALL is associated with the development of an immune defect, promoting development of both serious infectious complications at the initial stage of therapy and long-term persistent infections in patients during remission. The work studied naîve T and B cells in 49 children in the first acute period of ALL and 55 convalescent children at different terms of remission based on detection of T-cell receptor (TRECs) and K-deleting element (KRECs) excision circles by real-time PCR. As has been shown, development of ALL itself does not lead to suppression of naîve T- and B cell maturation. Specific therapy promotes development of a deep defect of both T and B cell immunity, deficit of naîve T cells persisting for not less than three years after statement of remission, whereas maturation of В cells is restored after termination of the intensive phase of therapy. Also, the inexpediency of using high dosages of methotrexate and cranial irradiation from the viewpoint of long-term immune reconstitution has been confirmed.

About the authors

Igor V. Obraztsov

Dmitry Rogachev Federal Research Centre of Paediatric Haematology, Oncology and Immunology, Ministry of Health of the Russian Federation; A.N.Ryzhykh State Research Centre of Coloproctology, Ministry of Health of the Russian Federation

Author for correspondence.
Email: igor_obraztsov@yahoo.com
Russian Federation

Maria A. Gordukova

G.N.Speransky Children’s City Clinical Hospital No 9, Moscow Department of Health

Email: dgkb9@zdrav.mos.ru
Russian Federation

Ekaterina V. Tsvetkova

Dmitry Rogachev Federal Research Centre of Paediatric Haematology, Oncology and Immunology, Ministry of Health of the Russian Federation

Email: info@fnkc.ru
Russian Federation

Elena V. Kononova

Russian Cardiology Research and Production Complex, Ministry of Health of the Russian Federation

Email: cclibr@cardio.ru
Russian Federation

Ivan Ya. Tomilin

Morozov City Children’s Clinical Hospital, Moscow Department of Health

Email: itomilin@yandex.ru
Russian Federation

Konstantin L. Kondratchik

Morozov City Children’s Clinical Hospital, Moscow Department of Health

Russian Federation

Aleksandr F. Karelin

Dmitry Rogachev Federal Research Centre of Paediatric Haematology, Oncology and Immunology, Ministry of Health of the Russian Federation

Email: info@fnkc.ru
Russian Federation

Andrey P. Prodeus

G.N.Speransky Children’s City Clinical Hospital No 9, Moscow Department of Health

Email: dgkb9@zdrav.mos.ru
Russian Federation

Aleksandr I. Karachunskiy

Dmitry Rogachev Federal Research Centre of Paediatric Haematology, Oncology and Immunology, Ministry of Health of the Russian Federation

Email: alexandr.karachunski@fccho-moscow.ru
Russian Federation

Alexandr G. Rumyantsev

Dmitry Rogachev Federal Research Centre of Paediatric Haematology, Oncology and Immunology, Ministry of Health of the Russian Federation

Email: Alexander.Rumyantsev@fccho-moscow.ru
Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Obraztsov I.V., Gordukova M.A., Tsvetkova E.V., Kononova E.V., Tomilin I.Y., Kondratchik K.L., Karelin A.F., Prodeus A.P., Karachunskiy A.I., Rumyantsev A.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.